ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Cimifugin improves intestinal barrier dysfunction by upregulating SIRT1 to regulate the NRF2/HO-1 signaling pathway.

Hui Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.